Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.

dc.contributor.author	Ruschil, Christoph
dc.contributor.author	Kemmerer, Constanze Louisa
dc.contributor.author	Abdelhak, Ahmed
dc.contributor.author	Scholl, Matthias
dc.contributor.author	Ziemann, Ulf
dc.contributor.author	Krumbholz, Markus
dc.contributor.author	Kowarik, Markus
dc.date.accessioned	2020-11-30T15:10:01Z
dc.date.available	2020-11-30T15:10:01Z
dc.date.issued	2020
dc.identifier.issn	1932-6203
dc.identifier.uri	http://hdl.handle.net/10900/109869
dc.language.iso	en	de_DE
dc.publisher	Public Library Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1371/journal.pone.0235449	de_DE
dc.subject.ddc	500	de_DE
dc.subject.ddc	610	de_DE
dc.title	Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200929220116_00495
utue.personen.roh	Kemmerer, C. L.
utue.personen.roh	Pernpeintner, V.
utue.personen.roh	Ruschil, C.
utue.personen.roh	Abdelhak, A.
utue.personen.roh	Scholl, M.
utue.personen.roh	Ziemann, U.
utue.personen.roh	Krumbholz, M.
utue.personen.roh	Hemmer, B.
utue.personen.roh	Kowarik, M. C.
dcterms.isPartOf.ZSTitelID	Plos One	de_DE
dcterms.isPartOf.ZS-Issue	Article e0235449	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE